GESTIFAR
Board
1 director, last change in 2022Statutory director
since 14-07-2022
term without a fixed end
listed in the 2025 annual accounts, filed on 19-06-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Article 11. Pouvoirs de l'organe d'administration S'il n'y a qu'un seul administrateur, la totalité des pouvoirs d'administration lui est…”deed of 14-07-2022
Mandates through the years
2 names, the dashed line is todayVANDERELST Jean-Christophe
Statutory director
Statutory director
Catherine BROWET
Statutory director
Statutory director
BoardEarlierend not dated
Mandates as a list
- VANDERELST Jean-Christophe
- Statutory director, from 30-09-2015 to date
- Catherine BROWET
- Statutory director, appointed by deed of 14-07-2022, no longer listed in the 2025 annual accounts
Control
Shareholder
Equity €444,329
Profit €458 in 2025 (profit €8,174 in 2024)
Checked score 70
Source: accounts ETS. VANDERELST 2025
1.36%
This company
GESTIFAR
Equity €1.7m
Profit €55,604 in 2025
Capital
- Capital
- €48,771.02
- Shares
- 1,251 in the deed of 01-07-2021
- Source
- deed of 14-07-2022
Owners through the years
as the annual accounts name themOwners as a list
- ETS. VANDERELST
Source: lists of holdings in the owners' accounts
Articles of association
deed of 14-07-2022 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Moitié cédant et moitié acquéreurs proportionnellement si plusieurs, tenus de solliciter agrément selon mêmes formalités si non actionnaires…”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Friday of June at 18:00
Capital transactions
Shareholders according to the deeds
At incorporation
deed of 01-07-2021 ↗
- Pharma Services (BE 0471.348.140) sole founder · 100% at incorporation
Capital over time
- 14-07-2022 Capital increase of €17,496.02 · to €48,771.02
- 14-07-2022 Converted to unavailable equity · €48,771.02
- 01-07-2021 Incorporation · €31,011.48 · 1,251 shares
- 01-07-2021 Capital increase of €30,988.52 · to €62,000 · from reserves
- 01-07-2021 Incorporation · €61,973.38 · 250 shares